# Statin in Hip Fracture

> **NCT01494090** · PHASE3 · TERMINATED · sponsor: **University Hospital, Brest** · enrollment: 36 (actual)

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01494090
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-09
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Decision of the Steering Committee. Recruitment more difficult and slower than expected.
- **Last updated:** 2012-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494090, "Statin in Hip Fracture". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01494090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*